It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2013.
2013 | Hyderabad, Telangana, India | ActiveSri Anantha Padmanabha Swamy Pharma Private Limited, a active private limited company, was established on 07 April 2013 in Hyderabad, Telangana, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: U74999TG2013PTC086824. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹9.00 Cr and a paid-up capital of ₹7.60 Cr.
It upholds a active non-compliant status. Employing 27 professional, Its leadership includes Vallabadas Satyanarayana Goud (Director), Bhaskar Karshikallam (Director), Renu Goyal (Director). It holds ₹5.16 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No 8-27, New Sai Nagar Colony, Road No 2 Canara Nagar, Peerjadiguda, Uppal, Hyderabad, Telangana, 500039.
U74999TG2013PTC086824
086824
07 April 2013
₹9.00 Cr
₹7.60 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sri Anantha Padmanabha Swamy Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vallabadas Satyanarayana Goud | Director | 07 Apr 2013 | Current |
| Bhaskar Karshikallam | Director | 07 Apr 2013 | Current |
| Renu Goyal | Director | 07 Apr 2013 | Current |
| Alok Agarwal | Director | 07 Apr 2013 | Current |
| Peddi Jagadishwar | Director | 07 Apr 2013 | Current |
| Naresh Kumar Peddi | Director | 07 Apr 2013 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sri Anantha Padmanabha Swamy Pharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 1.99% increase. The company also saw a substantial improvement in profitability, with a 153.58% increase in profit. The company's net worth Soared by an impressive increase of 32.61%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Sri Anantha Padmanabha Swamy Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹51,600,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 May 2014 | State Bank Of India | ₹5.16 Cr | Open |
Explore comprehensive loan charge details -
Sri Anantha Padmanabha Swamy Pharma has a workforce of 27 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sri Anantha Padmanabha Swamy Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Anantha Padmanabha Swamy Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sri Anantha Padmanabha Swamy Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Sri Anantha Padmanabha Swamy Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
A charge with State Bank Of India of Rs. 5.16 Cr registered on 19 May 2014 with Charge ID 10505474 was modified on 24 Apr 2023. was recorded as a recent event.
The activity A charge with State Bank Of India amounted to Rs. 5.16 Cr with Charge ID 10505474 was registered on 19 May 2014. was completed.
Vallabadas Satyanarayana Goud was appointed as a Director was appointed as a Director on 07 Apr 2013 & has been associated with this company since 12 years 8 months . was recorded as a recent event.
Bhaskar Karshikallam was appointed as a Director was appointed as a Director on 07 Apr 2013 & has been associated with this company since 12 years 8 months . was recorded as a recent event.
The CIN of Sri Anantha Padmanabha Swamy Pharma Private Limited is U74999TG2013PTC086824.
Sri Anantha Padmanabha Swamy Pharma Private Limited is headquartered at H.No 8-27, New Sai Nagar Colony, Road No 2 Canara Nagar, Peerjadiguda, Uppal, Hyderabad, Telangana, 500039.
Sri Anantha Padmanabha Swamy Pharma Private Limited was incorporated on 07 April 2013.
The current directors of Sri Anantha Padmanabha Swamy Pharma Private Limited are
The primary industry of Sri Anantha Padmanabha Swamy Pharma Private Limited is Manufacturing.
Sri Anantha Padmanabha Swamy Pharma Private Limited is unlisted.
The authorized capital of Sri Anantha Padmanabha Swamy Pharma Private Limited is ₹9.00 Cr, and the paid-up capital is ₹7.60 Cr.
The compliance status of Sri Anantha Padmanabha Swamy Pharma Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX